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Background: The current data regarding the correlation between the methicillin-resistant Staphylococcus aureus
(MRSA) clones carried in the nasal cavity and digestive tract are inadequate.
Methods: MRSA strains were isolated from both the feces and nasal swabs of 21 nasal-MRSA carriers ranging from
10 to 104 days of age treated at the neonatal intensive care units of two hospitals. The molecular epidemiological
characteristics of the isolates were determined: multilocus sequence types, spa-types, staphylococcal cassette
chromosome mec (SCCmec) types, carriage of four exotoxin genes, and genes contained in commercially
available kit.
Results: The feces of all nasal carriers contained MRSA at levels ranging from 4.0 × 102 to 2.8 × 108 colony forming
units/g feces. The MRSA clones isolated from the feces and the nasal swabs of each patient were the same. Four
MRSA clones, clonal complex (CC) 8-SCCmec IVl, CC8-SCCmec IVb, CC1-SCCmec IVa and CC5-SCCmec IIa were
identified from 21 patients. All CC8-SCCmec IVl strains and one of three CC5-SCCmec IIa strains carried the toxic
shock syndrome toxin gene.
Conclusions: The feces of tested MRSA carriers contained the same MRSA clones as the nasal isolates in
considerable amounts, suggesting that more careful attention should be paid for the handling of excrement in the
case of newborn babies or infants than that of adults.
Keywords: MRSA, Infection control, Intestinal carriage, Nosocomial infection, NICUIntroduction
Methicillin-resistant Staphylococcus aureus (MRSA) is
an important causative pathogen of healthcare-associated
infections. It is well known that MRSA strains carried by
an infected individuals, asymptomatic carrier or contami-
nated objects are transmitted via several routes, e.g., direct
contact with an infected individual, asymptomatic carrier
or contaminated object, the airborne transmission of
floating cells, etc. [1]. To control the infection of MRSA,
screening of MRSA nasal-carrier is conducted generally at
hospitals, since the mucosal membrane of the nasal cavity* Correspondence: teruybac@juntendo.ac.jp
2Department of Bacteriology, Faculty of Medicine, Juntendo University, 2-1-1
Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
3Department of Infection Control Science, Graduate School of Medicine,
Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
Full list of author information is available at the end of the article
© 2014 Nakao et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.is a well-known niche for Staphylococcal strains and nasal
colonization by MRSA is a well-established risk factor for
hospital-acquired MRSA infection among the causes of
nosocomial MRSA infection [2-6].
However, MRSA strains colonize at the area other
than nasal swabs, and the colonization at those areas
was regarded to be another risk factor for MRSA dis-
semination, too. Universal screening of all hospitalized
patients and selective screening limited to high-risk pa-
tients, such as those admitted to the intensive care unit or
scheduled for surgery, are routinely conducted [7]. About
40% of individuals with nasal colonization are also colo-
nized in other areas, including the throat, perineum and
axilla in adults [8,9]. Acton et al. reviewed cases involving
the intestinal carriage of S. aureus [10]. Ammeriaan et al.
reported that one of the causes of treatment failure forLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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colonized at extra-nasal sites [11]. Although MRSA infec-
tion is decreasing as results of infection control e.g., per-
forming standard precaution, active surveillance culture,
and cohorting, outbreak of MRSA strains still occurred. It
has been reported that invasive nosocomial infections pre-
dominantly occur in children younger than 1 year of age,
with an incidence of 14.7 per 100,000, versus 0.3-1.0 per
100,000 in older children [5] and the risk factors associated
with an increased rate of infections in the neonatal inten-
sive care unit (NICU) were suggested. These included the
presence of invasive devices, exposure to broad-spectrum
antibiotic agents, the use of parenteral nutrition, over-
crowding and poor staffing ratios [12].
We presumed that the feces of neonates and infants
might contain MRSA strains at considerable amount
and would have the possibility to serve as a potential
source of MRSA dissemination in the NICU if the con-
tact precautions are inconsistent. Furthermore, the re-
ports comparing the characteristics of MRSA strains
isolated from the stool and the nasal cavity in MRSA-
positive newborn babies and infants are inadequate. We
aimed at isolating and characterizing MRSA strains from
the feces of MRSA nasal carriers admitted to the NICU.
In this study, we estimated the number of MRSA strains
in feces and compared the genetic characteristics of
strains isolated from nasal swabs and feces.
Materials and methods
Subjects
Patients who were judged to be positive for MRSA by
nasal screening were selected from among neonate and
infant patients admitted to the NICUs between January
2013 and June 2013 at two university-affiliated tertiary
hospitals (J: Juntendo University Hospital and S: Juntendo
University Shizuoka Hospital). At the two hospitals,
screening for MRSA was performed on every patient at
admission, as well as every two weeks after hospitalization.
MRSA screening was conducted by inoculating nasal swabs
to CHROMagar MRSA (Kanto Chemical Co., Tokyo, Japan),
a selective choromogenic agar containing cephamycin [13].
Briefly, one hundred and sixty-nine patients underwent
nasal screening, including 100 males and 69 females ranging
from 0 to 171 days of age, with an average age of 19.6 days.
The average weight was 2,446 g, ranging from 576 to
4,481 g. A total of 26 of the 169 tested patients were found
to be MRSA carriers based on the screening specimens.
Among the 26 MRSA carriers, 21 patients were selected
for this study. Five patients were excluded; two patients
were excluded because they had been administered vanco-
mycin intravenously before sample collection for this
study, and three patients were excluded because their feces
could not be collected, e.g., they left the hospital before
sample collection. The subjects consisted of 11 males and10 females ranging from 10 to 104 days of age, with an
average age of 35.3 days. The average weight was 2,458 g,
ranging from 1,186 to 4,545 g. Of the 21 subjects, 18 ac-
quired MRSA during their stay in the hospitals and three
were positive on admission. No subjects had gastrointes-
tinal symptoms, such as diarrhea or vomiting.
Isolation of MRSA strains
Nasal strains were collected using SEEDSWAB No. 2
(Eiken chemical Co. Ltd, Tokyo, Japan) and samples
were inoculated onto two separate mannitol salt agar
plates, one containing 2 mg/L oxacillin and one 10 mg/L
cefoxitin. For fecal samples, 50 mg of stool was diluted
with saline to 5% w/v, then was further diluted 102-fold
and 104-fold. A 100 μl portion of each diluted sample was
inoculated on two separate mannitol-salt agars containing
2 mg/L of oxacillin and 10 mg/L of cefoxitin. The number
of MRSA strains in each fecal sample was estimated by
counting the number of yellow-colored colonies grown on
the selective medium. The yellow-colored colonies grown
on the plates after incubation at 37 degrees Celsius for 48
hours were regarded to be MRSA strains, which were later
confirmed using PCR of mecA and femA.
Validation and characterization of MRSA strains
We extracted chromosomal DNA from 1–4 yellow-colored
colonies on the agar plates using Cica Geneous® DNA
Extraction Reagent (Kanto chemical Co., Tokyo, Japan)
and conducted multiplex PCR using the Cica Geneus®
Staph POT KIT (Kanto chemical Co., Tokyo, Japan).
The kit contained 23 primer pairs identifying femA as a
marker of S. aureus, five genes related to Staphylococcal
cassette chromosome mec (SCCmec) elements, two genes
located on the S. aureus chromosome and 15 genes lo-
cated on mobile genetic elements, e.g., bacteriophages.
The strains were regarded to be MRSA when both mecA
and femA were identified.
Molecular characterization of MRSA
Based on the results of multiplex PCRs with Staph POT
kit, representative isolates from the nasal swabs and
feces were chosen and characterized according to the mul-
tilocus sequence type (MLST), spa type, SCCmec type
and presence of exotoxin genes. Chromosomal DNA was
extracted using the DNeasy Tissue Kit (Qiagen, Valencia,
USA). The SCCmec elements were identified using multi-
plex PCRs, as described by Kondo et al. [14]. The subtype
of each SCCmec type was determined using PCR with
primer pairs, as previously described. MLST and spa-type
were determined as previously described [15,16]. Carriage
of exotoxin genes, including eta and etb for exfoliative
toxins a and b, lukS-PV and lukF-PV for Panton-Valentine
Leukocidin and tst for Toxic shock syndrome toxin-1 (tst),
was detected using PCR, as previously described [17].
Nakao et al. Antimicrobial Resistance and Infection Control 2014, 3:14 Page 3 of 10
http://www.aricjournal.com/content/3/1/14Ethical approval
This study was approved by the Ethical Committee of
two participating hospitals and the written informed
consent was obtained from the person in parental au-
thority for the collection of samples and the publica-
tion of the analysed results.
Results
Isolation of MRSA strains from feces and nasal swabs
The feces of 21 MRSA screening-positive patients was
diluted and inoculated on two separate mannitol-salt
agar plates containing oxacillin or cefoxitin. Many yellow-
colored colonies grew on the agar plates in all patients
(Table 1). The number of yellow-colored colonies ranged
from 4.0 × 102 to 2.8 × 108 of colony forming units (CFU)/
g feces, with 1.7 × 107 CFU/g feces on average. At the same
time, the nasal swabs of 21 patients were streaked onto
two separate mannitol-salt agar plates containing oxa-
cillin or cefoxitin. Many yellow-colored colonies grew onTable 1 Isolation of MRSA strains from the nasal swabs
and feces of the patients in the NICU




stool samplea (CFU/g)Nasal swabs Feces
OXA CFX OXA CFX
A + + + - 4.0 × 106
B + + + + 1.6 × 105
C + + + + 2.9 × 106
D + + + + 3.1 × 106
E - + + + 1.6 × 103
F + + + + 2.4 × 106
G + + + + 2.4 × 107
H + + + + 4.7 × 106
I + + + - 6.0 × 104
J + + + - 1.6 × 103
K + + + - 1.1 × 107
L + NT + NT 6.0 × 106
M + + + - 1.6 × 105
N + + + + 2.9 × 106
O + + + + 2.5 × 106
P + + + + 2.8 × 108
Q + + + + 4.0 × 102
R + + + + 1.6 × 106
S + + + + 1.0 × 103
T + + + + 2.7 × 106
U + + + + 2.9 × 106
Abbreviations: OXA Oxacillin, CFX Cefoxitin, CFU colony forming units,
NT not tested.
aAverage number of yellow-colored colonies grown on agar plates
with oxacillin.the plates in all patients. One to four yellow-colored iso-
lates from the nasal and fecal samples were chosen at
random and subjected to multiple PCR with the Staph
POT KIT. All tested strains were mecA- and femA- positive
and therefore classified as MRSA. The data indicated that
the feces of the patients with nasal colonization contained
MRSA strains at significant amounts, although the num-
bers of MRSA colonies varied.
Comparisons of the carriage of ORFs by fecal and
nasal strains
To compare MRSA strains isolated from feces and nasal
swabs of each patient, we firstly conducted two multiplex
PCRs with Staph POT KIT by choosing 1–4 strains ob-
tained from the feces and nasal swabs of the 21 patients.
Two multiplex PCRs could amplify DNA fragments with re-
lated to SCCmec elements, two open reading frames (ORF)
on the chromosome and 15 ORFs on the mobile genetic el-
ements, e.g., lysogenized bacteriophages as listed in Table 2.
Representative banding patterns of amplified DNA frag-
ments from nasal and fecal strains isolated from the same
patient are shown in Figure 1. In 17 of the 21 patients,
exactly the same size and number of DNA fragments were
generated using DNA samples from the feces and nasal
swabs. In three patients (G, H and K), the dominant strains
were identical, but other strains exhibiting different amplifi-
cation patterns with ORFs in lysogenized bacteriophages
were also identified: a nasal isolate of patient G, a fecal iso-
late of patient H and a nasal isolate of patient K. In a patient
(L), different ORFs related to lysogenized bacteriophages
were generated, although the amplified DNA fragments in
association with the five ORFs in the SCCmec elements
and two ORFs on the chromosome were the same.
Molecular characterization of the MRSA strains
The MLST genotypes, SCCmec types and spa types were
determined in one representative isolate from each feces
sample among the 21 patients. Three clonal complexes
(CC1, CC5 and CC8), four SCCmec types (IIa, IVa, IVb and
IVl), and six spa types (2, 59, 606, 855, 1499 and 1500) were
identified. Consequently, 21 strains were classified into four
clones (Table 3). CC8-SCCmec IVl was the most prominent
clone (10 of 21), followed by CC1-SCCmec IVa (7 of 21),
CC5-SCCmec IIa (3 of 21) and CC8-SCCmec IVb (1 of 21).
The carriage of the four exotoxin genes was examined.
Eleven of the 21 strains carried the tst gene, including 10
CC8-SCCmec IVl strains and one CC5-SCCmec IIa strain.
In contrast, the eta, etb an lukS,F-PV genes were not iden-
tified in any of the tested strains. Next, we chose one rep-
resentative isolate from each nasal swab among the 21
patients and examined the SCCmec types, spa-types and
exotoxin repertoire. The characteristics of the nasal strains
were exactly identical to those of the fecal strains. Taken
together with the results of multiplex PCR shown in Table 2,
Table 2 Characterization of the isolates using multiple PCR
Patients Samples Number oftested strains





d on mobile genetic elements
A
Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV1998 4 / 4
Feces 2 IS1272 / type 2 ccr A 2 / 2 MW0919 2 / 2 SA1774 / SaGlm / SAV1998 2 / 2
B
Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV0881 / SA1801 4 / 4
Feces 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV0881 / SA1801 4 / 4
C
Nasal swab 4 mecI / type 2 ccrA /kdpC 4 / 4 SA2259 4 / 4 tnpB / SAV0898 / SAV0866 / SAV1974 /
SAV0855 / SaGlm / SLTorf175 / SAV0913 /
SLTorf182 / PV83orf2
4 / 4
Feces 4 mecI / type 2 ccrA /kdpC 4 / 4 SA2259 4 / 4 tnpB / SAV0898 / SAV0866 / SAV1974 /




Nasal swab 4 mecI / type 2 ccrA /kdpC 4 / 4 SA2259 4 / 4 tnpB / SAV0898 / SAV0866 / SAV1974 /
SAV0855 / SaGlm / SLTorf175 / SAV0913 /
SLTorf182 / PV83orf2
4 / 4
Feces 4 mecI / type 2 ccrA /kdpC 4 / 4 SA2259 4 / 4 tnpB / SAV0898 / SAV0866 / SAV1974 /




Nasal swab 2 IS1272 / type 2 ccr A 2 / 2 MW0919 2 / 2 SA1774 / SaGlm / SAV0881 / SA1801 2 / 2
Feces 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV0881 / SA1801 4 / 4
F
Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 tnpB / SAV0850 / SAV0898 / SAV0866 /
SAV1974 / SAV0855 / SaGlm /
SLTorf175 / PV83orf2
4 / 4
Feces 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 tnpB / SAV0850 / SAV0898 / SAV0866 /




Nasal swab 3 IS1272 / type 2 ccr A 3 / 3 MW0919 3 / 3 tnpB / SaGlm / SLTorf182 / PV83orf2 2 / 3
tnpB / SAV0850 / SAV0898 / SAV0866 /
SAV1974 / SAV0855 / SaGlm /
SLTorf175 / PV83orf2
1 / 3
Feces 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 tnpB / SaGlm / SLTorf182 / PV83orf2 4 / 4
H
Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 tnpB / SAV0898 / SAV0866 / SAV1974 /
SAV0855 / SaGlm / SLTorf175 /
SLTorf182 / PV83orf2
4 / 4
Feces 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 tnpB / SAV0898 / SAV0866 / SAV1974 /
SAV0855 / SaGlm / SLTorf175 /
SLTorf182 / PV83orf2
2 / 4
tnpB / SAV0850 / SAV0898 / SAV0866 /




Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 tnpB / SaGlm / SLTorf182 / PV83orf2 4 / 4
Feces 2 IS1272 / type 2 ccr A 2 / 2 MW0919 2 / 2 tnpB / SaGlm / SLTorf182 / PV83orf2 2 / 2
J
Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV0881 / SA1801 4 / 4
Feces 2 IS1272 / type 2 ccr A 2 / 2 MW0919 2 / 2 SA1774 / SaGlm / SAV0881 / SA1801 2 / 2
K
Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 tnpB / SAV0850 / SAV0898 / SAV0866 /
SAV1974 / SAV0855 / SaGlm / SLTorf175 /
SLTorf182 / PV83orf2
3 / 4
tnpB / SAV0898 / SAV0866 / SAV1974 /
SAV0855 / SaGlm / SLTorf175 /
SLTorf182 / PV83orf2
1 / 4
Feces 2 IS1272 / type 2 ccr A 2 / 2 MW0919 2 / 2 tnpB / SAV0850 / SAV0898 / SAV0866 /
SAV1974 / SAV0855 / SaGlm / SLTorf175 /
SLTorf182 / PV83orf2
2 / 2
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Table 2 Characterization of the isolates using multiple PCR (Continued)
L
Nasal swab 1 IS1272 / type 2 ccr A 1 / 1 MW0919 1 / 1 tnpB/ SAV1774 / SaGlm / SAV0881 / SAV1801 1 / 1




Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 tnpB / SAV0850 / SAV0898 / SAV0866 /
SAV1974 / SAV0855 / SaGlm /
SLTorf175 / PV83orf2
4 / 4
Feces 2 IS1272 / type 2 ccr A 2 / 2 MW0919 2 / 2 tnpB / SAV0850 / SAV0898 / SAV0866 /




Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 tnpB / SAV0850 / SAV0898 / SAV0866 /
SAV1974 / SAV0855 / SaGlm /
SLTorf175 / PV83orf2
4 / 4
Feces 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 tnpB / SAV0850 / SAV0898 / SAV0866 /




Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV0881 / SA1801 4 / 4
Feces 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV0881 / SA1801 4 / 4
P
Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV0881 / SA1801 4 / 4
Feces 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV0881 / SA1801 4 / 4
Q
Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV0881 / SA1801 4 / 4
Feces 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV0881 / SA1801 4 / 4
R
Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SAV0898 / SAV1774 / SAV0855 / SaGlm /
SLTorf175 / SAV0913 / SAV1998
4 / 4
Feces 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SAV0898 / SAV1774 / SAV0855 / SaGlm /
SLTorf175 / SAV0913 / SAV1998
4 / 4
S
Nasal swab 4 mecI / type 2 ccrA /kdpC 4 / 4 SA2259 4 / 4 tnpB / SAV0898 / SAV0866 / SAV1774 /
SAV0855 / SaGlm / SLTorf175 / SAV1801 /
SAV0913 / SAV1998 / PV83orf2
4 / 4
Feces 4 mecI / type 2 ccrA /kdpC 4 / 4 SA2259 4 / 4 tnpB / SAV0898 / SAV0866 / SAV1774 /
SAV0855 / SaGlm / SLTorf175 / SAV1801 /
SAV0913 / SAV1998 / PV83orf2
4 / 4
T
Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV0881 / SA1801 4 / 4
Feces 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV0881 / SA1801 4 / 4
U
Nasal swab 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV0881 / SA1801 4 / 4
Feces 4 IS1272 / type 2 ccr A 4 / 4 MW0919 4 / 4 SA1774 / SaGlm / SAV0881 / SA1801 4 / 4
Abbreviations: ORFs open reading frames.
aThe ORFs amplified by two multiplex PCR using the Cica Geneus Staph POT KIT are listed.
bPCR-positive ORFs related to SCCmec elements. The results of PCR of five genes, mecA, mecI, IS1272, type 2 ccrA, and kdpC located in type IIa SCCmec, are listed.
PCR-positive genes, except for mecA, are listed.
cPCR-positive ORFs located on the chromosomes of N315(SA2259) and MW2(MW0919).
dPCR-positive ORFs related to mobile genetic elements are listed. Fifteen ORFs were targeted for PCR, as follows: tnpB in the transposon Tn554, a ORF on the
genome islands SaGIm, and 12 ORFs on the lysogenized bacteriophages (SA1774 and SA1801 for phi N315; SAV0881, SAV0850, SAV0855, SAV0866, SAV0881,
SAV0898 and SAV0913 for phi Mu50A; SAV1974 and SAV1998 for phi Mu50B; orf 175 and orf 182 for phi SLT; and orf2 for phi PV83).
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MRSA clones as the strain isolated from the nasal swabs.
Three MRSA clones, CC5-SCCmec IIa, CC8-SCCmec
IVl and CC8-SCCmec IVb, were identified at the J hos-
pital and one clone, CC1-SCCmec IVa, was identified at
the S hospital.
Discussion
The feces of the infants contained significant amount of
MRSA pathogens
In this study, we found that the feces of all 21 patients,
from whom nasal cavity MRSA strains were isolated,contained MRSA. Adlerberth I. et al. reported the rates of
S. aureus isolation from feces were 40% to 80% in healthy
newborns and infants ranging from 7 days to 1 year of age
[18,19]. Acton et al. reported a detection rate of intestinal
carriage in healthy individuals and patients of 20% for S.
aureus and 9% for MRSA, which is approximately half of
that observed for nasal carriage [10]. Here we showed that
infant-nasal MRSA carriers consistently evacuate a lot of
cells of MRSA in their feces. Many reports advocate estab-
lishing better screening methods for identifying MRSA
carriers by evaluating optimum surveillance sites, e.g., the
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PatientsSamples
Figure 1 Comparisons of amplified DNA fragments with two multiplex PCRs. Abbreviations: n, isolates from nasal swabs; f, isolates from
feces. For PCR-1: 1, femA; 2, mecA; 3, IS1272; 4, kdpC; 5, tnpB in Tn554; 6, ORF SV0850 in phi mu1; 7, ORF SAV0898 in phi mu1; 8, ORF SAV0866 in
phi mu1; 9, ORF SA1774 in phi N315; 10, ORF SAV1974 in phi Sa 3mu; 11, ORF SAV0855 in phi mu1; 12, Genomic Island SaGIm. For PCR-2: 1, femA;
2, type 2 ccrA; 3, SA2259; 4, MW0919; 5, mecI; 6, ORF SAV0881 in phi mu1; 7, ORF 175 in phi SLT; 8, ORF SA1801 in phi N315; 9, ORF SAV0913 in
phi mu1; 10, ORF 182 in phi SLT; 11, ORF SAV1998 in phi Sa 3mu; 12, ORF 2 in phi PV83.
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surveillance program, nasal swabs are usually used be-
cause the method is easy to perform and has higher sensi-
tivity than other methods, while other sites have been
used for complementation [2,7,20].
A lot of cells of MRSA were isolated from the feces of
infants. The amount was greater than those reported in
adults, similar to the previous report [21]. The intestinal
flora of adults is generally occupied by established micro-
flora, which may help to prevent the colonization of newly
incorporated bacteria, known as the phenomenon of
“colonization resistance” [22]. In contrast, the intestinal
flora of neonates and infants, especially premature babies
admitted to the NICU, have not yet been established.
Therefore, we presume that MRSA strains are able to
propagate in or colonize the intestinal tract of infants
more efficiently than that of adults.
The feces of nasal MRSA carriers is associated with a high
risk for the dissemination of MRSA
In hospitals, the horizontal transmission of infective sub-
stances from an infected patient to another patient via
contact with medical staff is likely to occur, as previouslydescribed. However, transmission via direct contact can
be controlled by thoroughly implementing standard
precautions, regardless of the presence of MRSA
colonization. Furthermore, it is widely recognized that
the stool and vomit excreted from gastroenteritis patients
contain many pathogens, e.g., rotavirus, which can cause a
secondary infection [23-25]. We suggest that healthcare
workers should recognize the feces from nasal MRSA
carriers as a potential source of MRSA strains that
cause transmission, although gastrointestinal symp-
toms may not occur in all patients with fecal MRSA
colonization [26]. Feces containing MRSA may serve
as a source of contamination due to the possibility of
spreading to surrounding surfaces by contact with
healthcare workers’ hands. Our data suggested that
more careful attention should be paid for the handling
of excrement in the case of newborn babies or infants
than that of adults. When changing diapers or cloths
and bathing neonates and infants in the NICU, healthcare
workers may come in contact with MRSA. In the cases of
treatment failure, e.g., inappropriate precautions, hand
washing or hand hygiene using antiseptic agents, the
transmission of MRSA is likely to occur. Although there
Table 3 Molecular characterization of the MRSA strains isolated from the feces and nasal swabs
Strainsa MLST spa types SCCmec types Exotoxin genes Isolated atb
ST CC tst eta etb lukS, F-PV
Af 8 8 1499 IVl + - - - J
An NT NT 1499 IVl + - - -
Bf 8 8 606 IVl + - - - J
Bn NT NT 606 IVl + - - -
Cf 764 5 2 IIa - - - - Jc
Cn NT NT 2 IIa - - - -
Df 764 5 2 IIa - - - - Jc
Dn NT NT 2 IIa - - - -
Ef 8 8 606 IVl + - - - J
En NT NT 606 IVl + - - -
Ff 2763 1 1500 IVa - - - - S
Fn NT NT 1500 IVa - - - -
Gf 2764 1 855 IVa - - - - S
Gn NT NT 855 IVa - - - -
Hf 2764 1 855 IVa - - - - S
Hn NT NT 855 IVa - - - -
If 1 1 855 IVa - - - - S
In NT NT 855 IVa - - - -
Jf 8 8 606 IVl + - - - J
Jn NT NT 606 IVl + - - -
Kf 2763 1 855 IVa - - - - S
Kn NT NT 855 IVa - - - -
Lf 8 8 59 IVb - - - - J
Ln NT NT 59 IVb - - - -
Mf 2763 1 855 IVa - - - - S
Mn NT NT 855 IVa - - - -
Nf 2763 1 855 IVa - - - - S
Nn NT NT 855 IVa - - - -
Of 8 8 606 IVl + - - - J
On NT NT 606 IVl + - - -
Pf 8 8 606 IVl + - - - J
Pn NT NT 606 IVl + - - -
Qf 8 8 606 IVl + - - - J
Qn NT NT 606 IVl + - - -
Rf 8 8 606 IVl + - - - J
Rn NT NT 606 IVl + - - -
Sf 5 5 2 IIa + - - - Jc
Sn NT NT 2 IIa + - - -
Tf 8 8 606 IVl + - - - J
Tn NT NT 606 IVl + - - -
Uf 8 8 606 IVl + - - - J
Un NT NT 606 IVl + - - -
Abbreviations: f feces, n nasal swabs, NT not tested.
aStrains isolated from feces and nasal swabs of patients A-U.
bStrains isolated at two hospitals: Juntendo University Hospital (J) and Juntendo University Shizuoka Hospital (S).
cPatients C, D and S had already been colonized with MRSA before being transferred to hospital J from previous facilities.
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S. aureus including MRSA, there were few studies that
examined molecular epidemiological characteristics of
MRSA strains from two sources at the same time. In this
study, the MRSA clones contained in the feces were iden-
tical to those isolated from the nasal cavity, suggesting
that MRSA strains in the nasal cavity are carried into the
intestines, and the feces of MRSA nasal carriers should be
regarded as a source of transmission of MRSA. Since the
number of MRSA colonies in the feces was greater than
that observed in the nasal cavity, the risk of transmission
is higher in cases involving contact with feces than with
nasal secretions. However, the subjects of this study were
chosen from the patients who admitted to NICU. Thre-
fore, it is unclear whether the same results were obtained
in the cases of healthy infants or adult patients. Further
research need to be conducted to clarify these questions.
Characteristics MRSA clones isolated from feces and
nasal swabs
To know identities of MRSA clones contained in the
feces and nasal swabs, we firstly screened MRSA strains
in plural with multiplex PCRs that can identify ORFs in
SCCmec elements, some chromosomal genes of CC1 and
CC5 strains, and genes in mobile genetic elements, e.g.,
bacteriophage. We did not regard the method as a one to
be used instead of pulsed field gel electrophresis or to be
used to determine MRSA clone. Here we used the PCRs
as a compendium method to examine the identities of the
carriage of tested ORFs between several strains. A major-
ity of strain isolated from feces and nasal swabs of every
one person were the same, suggesting that the same clone
might be isolated. These data indicated that MRSA strains
at the nasal cavity entered to digestive tract, and propa-
gated there.
Further detailed investigation revealed characteristic
of MRSA strains of two hospitals. At the J hospital, the
CC8-SCCmec IVl clone was predominant, although
two other clones, CC5-SCCmec IIa and CC8-SCCmec
IVb, were also identified. At the S hospital, only the
CC1-SCCmec IVa clone was identified. Of the 21 carriers,
three were positive on admission to the units and 18 ac-
quired MRSA during their stay in hospitals. Three CC5-
SCCmec IIa strains were identified in the feces of patients
transferred from other facilities who carried MRSA before
hospitalization in the J hospital. These data suggest that
18 patients acquired the specific MRSA strains dissemi-
nated at each hospital. Type II SCCmec strains are still
dominant in Japanese hospitals, and there are reports that
type IV SCCmec strains are disseminated in the Japanese
community [27]. Yanagihara et al. reported that SCCmec
IV strains are predominantly distributed in the outpatient
clinics [28]. It is curious that the MRSA clones dissemi-
nated in the NICU were not identical to dominant MRSAclone disseminating in other wards, but rather were similar
to those isolated from the outpatient departments. It is well
known that the epidemiological distribution of MRSA
strains varies according to region and age [29-32]. MRSA
strains are classified into healthcare-associated (HA-MRSA)
and community-associated (CA-MRSA) strains [33,34].
Recent studies have shown that MRSA strains identified
in the community showed characteristics that were dis-
tinct from the HA-MRSA, and such CA-MRSA clones
are sometimes isolated from hospitals [30].
Recently, Iwao et al. reported that CC8-SCCmec IVl
strains that carry the toxic shock syndrome toxin gene have
been detected in the Japanese community [35]. This finding
is confirmed by our observation that the CC8-SCCmec IVl
strain is the dominant strain isolated from outpatient clinics
of dermatology (Hosoya et al. unpublished data). In the
current study, SCCmec IV strains were dominantly isolated
from patients admitted to our hospital at birth. These data
suggest that MRSA clones emerging in the community are
transmitted into and disseminated throughout the hospital.
Toxic shock syndrome toxin is a well-known super antigen
that causes neonatal toxic shock syndrome-like exanthema-
tous disease in neonates and infants [36]. All tst-positive
isolates produce a considerable amount of toxic shock
syndrome toxins. Fortunately, most patients did not
experience severe symptoms, although the possibility of
life-threatening syndrome remains. The root of transmis-
sion for the transfer of MRSA clones originating in the
Japanese community into the NICU remains unknown;
however, one possibility is that the pathogen is brought
into the hospital by the patient’s mother or other fam-
ily members. Studies investigating the transmission of
MRSA clones colonized in the nasal cavity in family
members are required to clarify this issue.
Conclusions
The feces of the investigated MRSA carriers contained
the same MRSA clones obtained from the nasal swabs
in considerable amounts, suggesting that the feces of
MRSA carriers is associated with a high risk for dissem-
inating MRSA.
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